Announcements & Circulars-Consun Pharmaceutical Group

Home
Approach To Consun
Company profile Management team Business Structure
Product Center
Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
R&D Innovation
R&D Platform R&D Team R&D Technology R&D Achievements
Investor Relations
Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact

中文

Investor Relations

Corporate Governance
Announcements & Circulars
Regular Reports
Documents available for inspection
IR Contact

Announcements & Circulars

2025-08-19 Interim Dividend for the six months ended 30 June 2025
2025-08-19 INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
2025-08-05 NOTICE OF BOARD MEETING
2025-08-04 DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS FOR WEALTH MANAGEMENT PRODUCTS
2025-08-01 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
2025-07-18 Next Day Disclosure Return
2025-07-16 Next Day Disclosure Return
2025-07-15 Next Day Disclosure Return
2025-07-14 Next Day Disclosure Return
2025-07-11 Next Day Disclosure Return

HomePrevious12 3 4 5 6 ...70 Next Last

Approach To Consun
Product Center
R&D Innovation
Investor Relations

400-930-1681

总机：（86）20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

Consun
Health Station
Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号 Design: uweb